Exemestane
About
Therapy type: Hormone therapy
Therapy strategy: Aromatase inhibition
Mappings
NCI Thesaurus: Exemestane (ncit:C1097)
RxNorm: exemestane (rxcui:258494, omop:4304164)
SNOMED: Exemestane (sctid:387017005, omop:1398399)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | ER positive, HER2-negative | Invasive Breast Carcinoma | Everolimus, Exemestane | |
| EMA (1) FDA (1) | HER2-negative, PR positive | Invasive Breast Carcinoma | Everolimus, Exemestane | |
| EMA (1) FDA (1) | ER positive, HER2-negative, PR positive | Invasive Breast Carcinoma | Everolimus, Exemestane | |
| EMA (1) FDA (1) | ER positive, HER2-negative, PR positive | Invasive Breast Carcinoma | Abemaciclib, Exemestane | |
| EMA (1) FDA (1) | ER positive, HER2-negative | Invasive Breast Carcinoma | Abemaciclib, Exemestane | |
| EMA (1) FDA (1) | HER2-negative, PR positive | Invasive Breast Carcinoma | Abemaciclib, Exemestane |